Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

11 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Safety and immunogenicity of COReNAPCIN, a SARS-CoV-2 mRNA vaccine, as a fourth heterologous booster in healthy Iranian adults: A double-blind, randomized, placebo-controlled, phase 1 clinical trial with a six-month follow-up.
Salehi M, Alavi Darazam I, Nematollahi A, Alimohammadi M, Pouya S, Alimohammadi R, Khajavirad N, Porgoo M, Sedghi M, Mahdi Sepahi M, Azimi M, Hosseini H, Mahmoud Hashemi S, Dehghanizadeh S, Khoddami V. Salehi M, et al. Among authors: pouya s. Int Immunopharmacol. 2024 May 17;134:112192. doi: 10.1016/j.intimp.2024.112192. Online ahead of print. Int Immunopharmacol. 2024. PMID: 38761778
SARS-CoV-2 mRNA-vaccine candidate; COReNAPCIN®, induces robust humoral and cellular immunity in mice and non-human primates.
Alimohammadi R, Porgoo M, Eftekhary M, Kiaie SH, Ansari Dezfouli E, Dehghani M, Nasrollahi K, Malekshahabi T, Heidari M, Pouya S, Alimohammadi M, Sattari Khavas D, Modaresi MS, Ghasemi MH, Ramyar H, Mohammadipour F, Hamzelouei F, Mofayezi A, Mottaghi SS, Rahmati A, Razzaznian M, Tirandazi V, Tat M, Borzouee F, Sadeghi H, Haji Mohammadi M, Rastegar L, Safar Sajadi SM, Ehsanbakhsh H, Bazmbar H, Baghernejadan Z, Shams Nouraei M, Pazooki P, Pahlavanneshan M, Alishah K, Nasiri F, Mokhberian N, Mohammadi SS, Akar S, Niknam H, Azizi M, Ajoudanian M, Moteallehi-Ardakani MH, Mousavi Shaegh SA, Ramezani R, Salimi V, Moazzami R, Hashemi SM, Dehghanizadeh S, Khoddami V. Alimohammadi R, et al. Among authors: pouya s. NPJ Vaccines. 2022 Sep 2;7(1):105. doi: 10.1038/s41541-022-00528-3. NPJ Vaccines. 2022. PMID: 36056015 Free PMC article.
The expression pattern of VISTA in the PBMCs of relapsing-remitting multiple sclerosis patients: A single-cell RNA sequencing-based study.
Derakhshani A, Asadzadeh Z, Baradaran B, Safarpour H, Rahmani S, Leone P, Abdoli Shadbad M, Hosseinkhani N, Ghasemigol M, Ayromlou H, Ahmadi H, Pouya S, Shojaee M, Tabrizi NJ, Miraki Feriz A, Safarzadeh E, Racanelli V. Derakhshani A, et al. Among authors: pouya s. Biomed Pharmacother. 2022 Apr;148:112725. doi: 10.1016/j.biopha.2022.112725. Epub 2022 Feb 17. Biomed Pharmacother. 2022. PMID: 35183994 Free article.
Plasma retinol-binding protein-4 and tumor necrosis factor-α are reduced in postmenopausal women after combination of different intensities of circuit resistance training and Zataria supplementation.
Tayebi SM, Saeidi A, Fashi M, Pouya S, Khosravi A, Shirvani H, Ahmadian M, Abderrahman AB, Hackney AC, Zouhal H. Tayebi SM, et al. Among authors: pouya s. Sport Sci Health. 2019 Dec;15(3):551-558. doi: 10.1007/s11332-019-00544-2. Epub 2019 Mar 15. Sport Sci Health. 2019. PMID: 31885723 Free PMC article.
Vortices in the wake of a femtosecond laser filament.
Ryabtsev A, Pouya S, Koochesfahani M, Dantus M. Ryabtsev A, et al. Among authors: pouya s. Opt Express. 2014 Oct 20;22(21):26098-102. doi: 10.1364/OE.22.026098. Opt Express. 2014. PMID: 25401642 Free article.
11 results